Skip to content
SecularTimes
  • HOME
  • WORLD
  • POLITICS
  • ENTERTAINMENT
  • AUTOMOBILE
  • BUSINESS
  • TECHNOLOGY
  • LIFESTYLE
  • HEALTH
  • MORE
    • COVID-19
    • COMICS
    • SPORTS
    • SCIENCE
    • TRAVEL

Roche Holding AG

Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

by Joseph Addison
Swiss pharma giant Roche’s first-quarter sales edge higher as its emerges from post-Covid-19 slump

A logo at the Roche Holding AG headquarters in Basel, Switzerland, on Thursday, Feb. 1, 2024. Bloomberg | Getty Images Swiss pharmaceutical company Roche on Wednesday reported a modest uptick …

Read more

Top 15 companies to work for in Singapore in 2024

by Joseph Addison
Top 15 companies to work for in Singapore in 2024

These are the top companies to work for in Singapore in 2024, according to LinkedIn. Carlina Teteris | Moment | Getty Images Banks dominated the top 5 best companies in …

Read more

GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

by Sven Aggesen
GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks …

Read more

GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

by Sven Aggesen
GRANOLAS stocks power Europe to record highs, drawing Magnificent 7 comparisons

The German share price index DAX graph is pictured at the stock exchange in Frankfurt, Germany, January 19, 2024.  Staff | Reuters Over the last 12 months, just 11 stocks …

Read more

Novo Nordisk, Eli Lilly are tackling supply issues

by Tudur Aled
Novo Nordisk, Eli Lilly are tackling supply issues

Injection pens of Novo Nordisk’s weight-loss drug Wegovy are shown in this photo illustration in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters The insatiable demand for weight loss …

Read more

Boehringer Ingelheim, Terns, Viking may join market

by Tudur Aled
Boehringer Ingelheim, Terns, Viking may join market

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity.  Michael Siluk …

Read more

Market likes AI technology for advertising, not health care

by Joseph Addison
Market likes AI technology for advertising, not health care

CNBC’s Jim Cramer on Tuesday shared what he learned from his two days at JPMorgan‘s health-care conference. He marveled at the myriad of uses for generative artificial intelligence in health …

Read more

Cramer names biopharma companies as industry mergers start to accrue

by Joseph Addison
Cramer names biopharma companies as industry mergers start to accrue

CNBC’s Jim Cramer on Friday pointed out the number of biopharma mergers and acquisitions that have closed or been announced over the last few months. He told investors to keep …

Read more

2024 expectations for Wegovy, Ozempic, Zepbound

by Tudur Aled
2024 expectations for Wegovy, Ozempic, Zepbound

George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market.  The drugs skyrocketed …

Read more

Roche enters obesity market with Carmot takeover

by Joseph Addison
Roche enters obesity market with Carmot takeover

BRAZIL – 2021/11/26: In this photo illustration a F. HoffmannLa Roche AG logo is seen on a screen and a hand holding a pill. (Photo Illustration by Rafael Henrique/SOPA Images/LightRocket …

Read more

Older posts
Newer posts
← Previous Page1 Page2 Page3 Next →

Recent Posts

  • The Role of Technology in Driving Innovation and Growth in UK Businesses
  • Steven Bartlett accused of amplifying dangerous health claims on his podcast | Podcasting
  • 2025 Volkswagen Taos Is Exactly What You Think It’s Going To Be
  • Canadians concerned country’s children are too soft, with no coping skills: survey
  • Apple MacBook Pro 16-inch (M4 Pro and M4 Max) review: still on top

Recent Comments

No comments to show.
  • ABOUT US
  • CONTACT US
  • PRIVACY POLICY
  • COOKIES POLICY
  • DISCLAIMER
  • TERMS OF USE
  • DMCA
© 2025 SecularTimes • Built with GeneratePress